MELISSA PEET: Open Payments
NPI 1154046548 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$124 in 5 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $229 · 2025 $124
Food & beverage: $124
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $53 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: AUSTEDO XR, INGREZZA, CAPLYTA, COBENFY.
Industry payments across CA — which companies pay providers there.
